Financhill
Back

MannKind Corp. 10K Form

Sell
14

MNKD
MannKind Corp.

Last Price:
$2.49
Seasonality Move:
6.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive MNKD News And Ratings

See the #1 stock for the next 7 days that we like better than MNKD

MNKD Financial Statistics

Sales & Book Value

Annual Sales: $349M
Cash Flow: $-9.4M
Price / Cash Flow: 55.89
Annual Sales: $-0.17
Price / Book: 0

Profitability

EPS (TTM): 0.01680
Net Income (TTM): $5.9M
Gross Margin: $257M
Return on Equity: 0%
Return on Assets: 1.17%

MannKind Corp. Earnings Forecast

Key MannKind Corp. Financial Ratios

  • The Gross Profit Margin over the past 26 years for MNKD is 73.66%.
  • The Selling, General & Administrative Expenses for MNKD have been equal to 41.30% of Gross Profit Margin.
  • The Research & Development expenses have been 19.01% of Revenue.
  • The Interest Expense is 648.63% of Operating Income.
  • The Net Earning history of MNKD is 1.68% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 16 years.

MannKind Corp. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MNKD
CUSIP: 56400P
Website: mannkindcorp.com

Debt

Debt-to-Equity Ratio: -9.28
Current Ratio: 1.7
Quick Ratio: 1.23

Price-to-Earnings

Trailing P/E Ratio: 130.79
Forward P/E Ratio: 10.75

MNKD Technical Analysis vs Fundamental Analysis

Sell
14
MannKind Corp. (MNKD) is a Sell

Is MannKind Corp. a Buy or a Sell?

  • MannKind Corp. stock is rated a Sell
    The current MannKind Corp. [MNKD] share price is $2.50. The Score for MNKD is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.